TITLE

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

AUTHOR(S)
Dendukuri, Nandini; Costa, Vania; McGregor, Maurice; Brophy, James M.
PUB. DATE
July 2005
SOURCE
CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p167
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract Background The recent increase in the number and severity of cases of nosocomial Clostridium difficile-associated diarrhea (CDAD) has prompted interest in the use of probiotics for the prevention and treatment of this disease. We performed a systematic review of randomized controlled trials to assess the effectiveness of probiotic therapy. Methods We searched the PubMed, EMBASE, INAHTA, HEN and Cochrane Collaboration databases to identify trials in which the prevention or treatment of CDAD with probiotic therapy was the primary or secondary outcome. We extracted data on the number of patients randomly assigned to receive probiotic or placebo, the number of patients with CDAD, the type of probiotic, criteria for diagnosing CDAD, persistence of infection after treatment, compliance and adverse effects. Results We identified 4 eligible studies in which prevention (n = 1) or treatment (n = 3) of CDAD was the primary outcome. The benefit of probiotic therapy seen in 2 of the studies was restricted to subgroups characterized by severe CDAD and increased use of vancomycin. The remaining 2 studies were too methodologically flawed for us to draw meaningful conclusions. We also identified 4 trials in which prevention of antibiotic-associated diarrhea with probiotics was the primary outcome and prevention of CDAD a secondary outcome. These studies were limited primarily by too few CDAD cases and provided no evidence of effective prophylaxis. Overall, heterogeneity in choice and dose of probiotic and in criteria for diagnosing CDAD makes it difficult to synthesize information from the 8 studies. Interpretation Studies conducted to date provide insufficient evidence for the routine clinical use of probiotics to prevent or treat CDAD. Better designed and larger studies are needed.
ACCESSION #
17557271

 

Related Articles

  • Probiotics and Antibiotic-Associated Diarrhea (AAD).  // Clinical Infectious Diseases;8/1/2006, Vol. 43 Issue 3, preceding p271 

    The article discusses the probiotics for the prevention of antibiotic-associated diarrhea. According to studies, the most important means of prevention of AAD is the avoidance of unnecessary antibiotic therapy which is also relevant of Clostridium difficile-associated diarrhea. Two specific...

  • Antimotility Agents for the Treatment of Clostridium difficile Diarrhea and Colitis. Koo, Hoonmo L.; Koo, Diana C.; Musher, Daniel M.; DuPont, Herbert L. // Clinical Infectious Diseases;3/1/2009, Vol. 48 Issue 5, p598 

    Antimotility agent use for the treatment of Clostridium difficile infection (CDI) is discouraged. We reviewed the literature and unpublished postmarketing surveillance reports regarding antimotility treatment of CDI. Twenty reports met inclusion criteria, describing 55 patients with CDI who were...

  • Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections. Mullane, Kathleen M.; Miller, Mark A.; Weiss, Karl; Lentnek, Arnold; Golan, Yoav; Sears, Pamela S.; Shue, Youe-Kong; Louie, Thomas J.; Gorbach, Sherwood L. // Clinical Infectious Diseases;9/1/2011, Vol. 53 Issue 5, p440 

    Background. Treatment guidelines recommend stopping all implicated antibiotics at the onset of Clostridium difficile infection (CDI), but many individuals have persistent or new infections necessitating the use of concomitant antibiotics (CAs). We used data from 2 phase 3 trials to study effects...

  • Probiotics don't stop diarrhea.  // Clinical Advisor;Sep2013, Vol. 16 Issue 9, p28 

    The article offers information on a study by Stephen K. Allen and published in "The Lancet" that investigated the efficacy of probiotic supplements in preventing antibiotic-associated diarrhea or diarrhea caused by Clostridium difficile in elderly patients.

  • Corrigendum: Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis. Kwok, Chun Shing; Arthur, Aaron Kobina; Anibueze, Chukwudubem Ifeanyichukwu; Singh, Sonal; Cavallazzi, Rodrigo; Loke, Yoon Kong // American Journal of Gastroenterology;Jan2014, Vol. 109 Issue 1, p144 

    A correction to the article "Risk of Clostridium difficile Infection With AcidSuppressing Drugs and Antibiotics: Meta-Analysis" that was published in the July 2012 issue is presented.

  • Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. Moore, John H.; Pinheiro, Caio C. D.; Zaenker, Edna I.; Bolick, David T.; Kolling, Glynis L.; van Opstal, Edward; Noronha, Francisco J. D.; De Medeiros, Pedro H. Q. S.; Rodriguez, Raphael S.; Lima, Aldo A.; Guerrant, Richard L.; Warren, Cirle A. // PLoS ONE;7/16/2015, Vol. 10 Issue 7, p1 

    Background: Clostridium difficile is a major identifiable and treatable cause of antibiotic-associated diarrhea. Poor nutritional status contributes to mortality through weakened host defenses against various pathogens. The primary goal of this study was to assess the contribution of a reduced...

  • Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile. Merrigan, Michelle M.; Venugopal, Anilrudh; Roxas, Jennifer L.; Anwar, Farhan; Mallozzi, Michael J.; Roxas, Bryan A. P.; Gerding, Dale N.; Viswanathan, V. K.; Vedantam, Gayatri // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Clostridium difficile is a leading cause of antibiotic-associated diarrhea, and a significant etiologic agent of healthcare-associated infections. The mechanisms of attachment and host colonization of C. difficile are not well defined. We hypothesize that non-toxin bacterial factors, especially...

  • Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea. Johnston, Bradley C.; Ma, Stephanie S. Y.; Goldenberg, Joshua Z.; Thorlund, Kristian; Vandvik, Per O.; Loeb, Mark; Guyatt, Gordon H. // Annals of Internal Medicine;12/18/2012, Vol. 157 Issue 12, p878 

    Background: Antibiotic treatment may disturb the resistance of gastrointestinal flora to colonization. This may result in complications, the most serious of which is Clostridium difficile-associated diarrhea (CDAD) Purpose: To assess the efficacy and safety of probiotics for the prevention of...

  • Epidemiology, Clinical Manifestations, and Outcome of Clostridium difficile-Associated Diarrhea. Anand, Ajay; Bashey, Baquar; Mir, Tanveer; Glatt, Aaron E. // American Journal of Gastroenterology;Apr1994, Vol. 89 Issue 4, p519 

    Objective: Clostridium difficile gastrointestinal disease is an important nosocomial infection and is associated with recent antibiotic use. This study evaluated C. difficile-associated diarrhea (CDAD) over a 2-yr period. Methods: All 60 patients with C. difficile enterotoxin in their stools,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics